Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1/2 7Phase 1 7Phase 3 6Phase 4 3Phase NA 2Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Gastrointestinal 2Endocrine 2

Conditions

Colorectal Neoplasms 1430Pancreatic Neoplasms 664Colonic Neoplasms 655Carcinoma, Hepatocellular 631Rectal Neoplasms 571Stomach Neoplasms 547Esophageal Neoplasms 384Liver Neoplasms 279Breast Neoplasms 278Neoplasms 243Gastrointestinal Neoplasms 214Lung Neoplasms 175Prostatic Neoplasms 137Barrett Esophagus 127Colonic Polyps 115Cholangiocarcinoma 114Motor Activity 101Ovarian Neoplasms 75Head and Neck Neoplasms 73Neoplasm Metastasis 64Adenoma 61Uterine Cervical Neoplasms 58Anus Neoplasms 54Anastomotic Leak 54Carcinoma, Non-Small-Cell Lung 53Colorectal Neoplasms, Hereditary Nonpolyposis 51Biliary Tract Neoplasms 51Postoperative Complications 49Urinary Bladder Neoplasms 47Esophageal Squamous Cell Carcinoma 47

Interventions

Resveratrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Gastro-enteropancreatic neuroendocrine tumor × Gastrointestinal × Clear all
NCT06256705 2025-09-22

OPERANDI-NET

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting
80 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT01476592 2019-11-18

A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors

University of Wisconsin, Madison

Phase NA Completed
7 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡